NewsRx

Search our medical news database

Hepatology

Rho-kinase and MLCK regulate sinusoidal endothelial fenestrae organization

Published in Hepatitis Weekly, March 21st, 2005

Rho-kinase and MLCK regulate sinusoidal endothelial fenestrae (SEF) organization.

"The presence of actin filaments in the neighborhood" of SEF "indicates that the cytoskeleton of sinusoidal endothelial cells (SEC) plays an important role in the modulation of SEF," hepatologists in Japan explained.

In their study, H. Yokomori and coauthors at the Kitasato Medical Center Hospital "examined the roles of Rho-kinase and myosin light chain kinase (MLCK) in the organization of SEF."

"Cultured SEC were treated with MLCK inhibitor (ML-7) and Rho-kinase inhibitor (Y-27632)," and "SEF morphology was observed by scanning electron microscopy,"...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook